Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 24.05
-0.65 (-2.63%)
Jul 30, 2026, 11:12 AM CST
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 3.73 billion as of July 29, 2026. Its market cap has decreased by -22.45% in one year.
Market Cap
3.73B
Enterprise Value
2.37B
Revenue
54.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.05
ChartMarket Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 3.73B, a decrease of -32.62%. That is a compound annual growth rate of -7.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.72B | -6.63% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Biotechnology | 4.51B |
| Pharmosa Biopharm | 4.46B |
| Sinew Pharma | 4.41B |
| Genovate Biotechnology | 3.65B |
| Senhwa Biosciences | 3.52B |
| OBI Pharma | 3.46B |
| BioGend Therapeutics | 3.27B |
| Great Novel Therapeutics Biotech & Medicals | 3.23B |